De første 330 patienter blev vurderet centralt (responsrate 6, 2%); 401 patienter blev vurderet af investigator (responsrate 11, 2%).
The first 330 patients were centrally assessed (response rate 6.2%); 401 patients were investigator- assessed (response rate 11.2%).